Molecular signatures in hepatocellular carcinoma: A step toward rationally designed cancer therapy.

Abstract:

:Molecular characterization of hepatocellular carcinoma (HCC) has greatly improved our understanding of disease pathogenesis. Mutational analysis, RNA and microRNA expression profiling, and epigenetic characterization have revealed common aberrations in oncogenes and tumor suppressors that correlate with disease biology and serve as a guide for the rational design of targeted therapies. These approaches have also led to the discovery of novel targets, including mutations in isocitrate dehydrogenase and chromatin remodeling enzymes. With the advent of immunotherapy, RNA expression profiling of the tumor microenvironment has identified a subset of HCC with high lymphocyte infiltration that may benefit from checkpoint inhibitor therapy. Molecular signatures thus capture the biology of a tumor, providing a supplement to current staging schema, which are based on tumor size and number, for more accurate prognostication of recurrence risk and survival. Molecular signatures may also be used to guide interventional therapy by defining those most suitable for transplantation or locoregional therapy rather than surgical resection. Finally, a multiomics approach involves the aggregation and analysis of multiple signatures for a more comprehensive characterization of pathogenic mechanisms. This broader approach attempts to address issues with signaling pathway cross-talk and redundancy, which have greatly limited the potential value of targeted therapies to date. Cancer 2018. © 2018 American Cancer Society.

journal_name

Cancer

journal_title

Cancer

authors

Erstad DJ,Fuchs BC,Tanabe KK

doi

10.1002/cncr.31257

subject

Has Abstract

pub_date

2018-08-01 00:00:00

pages

3084-3104

issue

15

eissn

0008-543X

issn

1097-0142

journal_volume

124

pub_type

杂志文章,评审

相关文献

CANCER文献大全
  • Effectiveness of high-dose MCNU therapy and hematopoietic stem cell autografts treatment of childhood acute leukemia/lymphoma with high-risk features.

    abstract::Clinical and pharmacokinetic studies were performed regarding the toxicity of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) with other drugs, in conjunction with a peripheral blood stem cell autograft (PBSCT), for treating 26 children with acute leukemia or lymphoma associated wit...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19910401)67:7<1830::aid-cncr2820

    authors: Takaue Y,Watanabe T,Hoshi Y,Abe T,Matsunaga K,Saito S,Hirao A,Kawano Y,Ninomiya T,Kuroda Y

    更新日期:1991-04-01 00:00:00

  • A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate carcinoma. Analysis of time to progression. CASODEX Combination Study Group.

    abstract:BACKGROUND:A randomized, multicenter trial, double-blind for antiandrogen therapy, compared the antiandrogens bicalutamide and flutamide, each combined with luteinizing hormone-releasing hormone analogue therapy (LHRH-A) in 813 patients with Stage D2 prostate carcinoma. An analysis of time to progression (median follow...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1002/(sici)1097-0142(19961115)78:10<2164::aid-c

    authors: Schellhammer PF,Sharifi R,Block NL,Soloway MS,Venner PM,Patterson AL,Sarosdy MF,Vogelzang NJ,Chen Y,Kolvenbag GJ

    更新日期:1996-11-15 00:00:00

  • Benign breast lesions at risk of developing cancer--a challenging problem in breast cancer screening programs: five years' experience of the Breast Cancer Screening Program in Verona (1999-2004).

    abstract:BACKGROUND:Cytology and core-needle biopsies are not always sufficient to exclude malignancy in benign breast lesions (BBL) that are at risk of developing cancer, and open biopsy often is mandatory. In screening programs, open biopsies performed for lesions that are at risk of developing malignancy are considered benig...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.24038

    authors: Manfrin E,Mariotto R,Remo A,Reghellin D,Falsirollo F,Dalfior D,Bricolo P,Piazzola E,Bonetti F

    更新日期:2009-02-01 00:00:00

  • Alterations of peripheral blood B-lymphocyte populations in plasma cell disorders.

    abstract::Peripheral blood lymphocytes of patients with multiple myeloma, macroglobulinemia, and monoclonal gammopathy of uncertain significance were analyzed for B cells, and cells bearing kappa light chains and lambda light chains on their surfaces. Compared with controls, the number of B cells were decreased in all three gro...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19811115)48:10<2211::aid-cncr282

    authors: Dillman RO,Royston I,Meserve BL,Griffiths JC

    更新日期:1981-11-15 00:00:00

  • A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma.

    abstract:BACKGROUND:Thalidomide is an antiangiogenic agent with immune modulating potential. The objective of this study was to determine response rates among women who were treated for recurrent ovarian cancer using topotecan with or without thalidomide. METHODS:Women were enrolled in this multicenter, prospective, randomized...

    journal_title:Cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/cncr.23164

    authors: Downs LS Jr,Judson PL,Argenta PA,Ghebre R,Geller MA,Bliss RL,Boente MP,Nahhas WA,Abu-Ghazaleh SZ,Chen MD,Carson LF

    更新日期:2008-01-15 00:00:00

  • Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant radiation and tamoxifen.

    abstract:BACKGROUND:The purpose of the current study was to examine patient selection for an aromatase inhibitor in breast cancer patients who were free from adverse events 5 years after treatment with tamoxifen. METHODS:In all, 471 women were treated with breast-conserving surgery, axillary lymph node dissection, and radiatio...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.22291

    authors: Freedman GM,Anderson P,Li T,Ross E,Swaby R,Goldstein L

    更新日期:2006-12-01 00:00:00

  • Solid tumor models for the assessment of different treatment modalities. XIII. Comparison of response and recovery of host and solid tumor to cyclophosphamide and radiation.

    abstract::A study of the effects of local tumor radiation alone (1500R) and cyclophosphamide alone (150 mg/kg) on the experimental solid tumor rat hepatoma 3924A has been completed. Cyclophosphamide was more effective in controlling tumor growth than either radiation or 5-fluorouracil (5-FU) (150 mg/kg) previously reported. Par...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19800601)45:11<2793::aid-cncr282

    authors: Looney WB,Hopkins HA,Grover WH,Macleod MS,Ritenour ER,Hobson AS

    更新日期:1980-06-01 00:00:00

  • Prognostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer. The influence of the pattern of immunostaining and adjuvant therapy.

    abstract:BACKGROUND:The influence of HER-2/neu on prognosis of breast cancer is controversial. The authors investigated by immunohistochemistry in node-positive disease the influence of the pattern of immunostaining (membranous or cytoplasmic) on outcome and the prognostic significance of this marker in patients receiving or no...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/1097-0142(19940501)73:9<2359::aid-cncr2820

    authors: Têtu B,Brisson J

    更新日期:1994-05-01 00:00:00

  • c-KIT mutation analysis for diagnosis of gastrointestinal stromal tumors in fine needle aspiration specimens.

    abstract:BACKGROUND:Gastrointestinal stromal tumors (GISTs) are a specific clinicopathologic entity characterized by activating mutations in the c-KIT gene. These mutations are associated with increased immunohistochemical staining for the c-KIT protein. Because many GISTs display a definitive response to the KIT inhibitor imat...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.21064

    authors: Willmore-Payne C,Layfield LJ,Holden JA

    更新日期:2005-06-25 00:00:00

  • N-terminal peptide of type III procollagen: a possible predictor of colorectal carcinoma recurrence.

    abstract:BACKGROUND:The first step of colorectal carcinoma spread depends on the ability of the tumor cells to degrade and invade the extracellular matrix (ECM). The objectives of the current study were to evaluate the serum pattern of laminin, C-terminal peptide of Type I (PIP), and N-terminal peptide of Type III (PIIIP) proco...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/(sici)1097-0142(19970401)79:7<1299::aid-cn

    authors: Plebani M,Basso D,Roveroni G,De Paoli M,Galeotti F,Corsini A

    更新日期:1997-04-01 00:00:00

  • Comparison of dynamic and conventional computed tomography, angiography, and ultrasonography in the staging of renal cell carcinoma.

    abstract::A prospective study was carried out on 22 patients to assess the diagnostic ability to stage renal cell carcinoma by computed tomography, dynamic computed tomography, arteriography, ultrasonography, and radionuclide scanning. Dynamic computed tomography remedied the most consequential diagnostic shortcomings of conven...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19841115)54:10<2205::aid-cncr282

    authors: Lang EK

    更新日期:1984-11-15 00:00:00

  • A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma.

    abstract:BACKGROUND:A prospective, randomized study was performed to determine the efficacy of neoadjuvant chemotherapy over radiotherapy alone in patients with locally advanced nasopharyngeal carcinoma. METHODS:From January 1991 to December 1998, 80 patients were enrolled in this study. Patients with locoregional carcinoma of...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1002/cncr.10473

    authors: Hareyama M,Sakata K,Shirato H,Nishioka T,Nishio M,Suzuki K,Saitoh A,Oouchi A,Fukuda S,Himi T

    更新日期:2002-04-15 00:00:00

  • Genetic and pathologic findings in a kindred with hereditary sarcoma, breast cancer, brain tumors, leukemia, lung, laryngeal, and adrenal cortical carcinoma.

    abstract::A familial cancer aggregation comprising sarcomas, brain tumors, leukemias, and carcinomas of breast, larynx, lung, adrenal, cortex, and other sites has been studied from a pathologic--genetic standpoint. Based upon sibships segregating for cancer, the genetic segregation parameter is estimated to be 45.6 +/- 11% whi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197805)41:5<2055::aid-cncr282041

    authors: Lynch HT,Mulcahy GM,Harris RE,Guirgis HA,Lynch JF

    更新日期:1978-05-01 00:00:00

  • Activity of the oral mitogen-activated protein kinase kinase inhibitor trametinib in RAS-mutant relapsed or refractory myeloid malignancies.

    abstract:BACKGROUND:RAS/RAF/mitogen-activated protein kinase activation is common in myeloid malignancies. Trametinib, a mitogen-activated protein kinase kinase 1 (MEK1)/MEK2 inhibitor with activity against multiple myeloid cell lines at low nanomolar concentrations, was evaluated for safety and clinical activity in patients wi...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.29986

    authors: Borthakur G,Popplewell L,Boyiadzis M,Foran J,Platzbecker U,Vey N,Walter RB,Olin R,Raza A,Giagounidis A,Al-Kali A,Jabbour E,Kadia T,Garcia-Manero G,Bauman JW,Wu Y,Liu Y,Schramek D,Cox DS,Wissel P,Kantarjian H

    更新日期:2016-06-15 00:00:00

  • High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma.

    abstract:BACKGROUND:In a previous study of gene array data, the authors identified survivin as a candidate marker of aggressiveness in clear cell renal cell carcinoma (ccRCC). What remained in question was whether survivin expression at the protein level is an independent predictor of disease progression and cancer-specific sur...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.21952

    authors: Parker AS,Kosari F,Lohse CM,Houston Thompson R,Kwon ED,Murphy L,Riehle DL,Blute ML,Leibovich BC,Vasmatzis G,Cheville JC

    更新日期:2006-07-01 00:00:00

  • Religion, spirituality, and health outcomes in cancer: A case for a meta-analytic investigation.

    abstract::A growing body of research shows that a majority of patients with cancer report having religious and spiritual (R/S) beliefs, engaging in R/S behaviors, or deriving comfort from R/S experiences. These studies have been reviewed but not subjected to rigorous critical analysis. A meta-analytic approach is needed to prov...

    journal_title:Cancer

    pub_type: 杂志文章,meta分析

    doi:10.1002/cncr.29349

    authors: Salsman JM,Fitchett G,Merluzzi TV,Sherman AC,Park CL

    更新日期:2015-11-01 00:00:00

  • Fine structural characterization of melanosomes in dysplastic nevi.

    abstract::This study characterized the fine structure of melanosomes in melanocytes of the dysplastic nevi in six cases with lentiginous melanocytic dysplasia and one case with epithelioid-cell melanocytic dysplasia, and compared that structure with those of common melanocytic nevi and malignant melanoma. It was found that: fin...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19850701)56:1<111::aid-cncr28205

    authors: Takahashi H,Horikoshi T,Jimbow K

    更新日期:1985-07-01 00:00:00

  • Ductal carcinoma in situ of the male breast.

    abstract:BACKGROUND:Ductal carcinoma in situ (DCIS) of the male breast is an uncommon disease, accounting for approximately 7% of all male breast carcinomas. Compared with invasive carcinomas of the breast, the prognosis associated with DCIS in men is excellent; however, clinical features, pathology, and treatment of this disea...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19940815)74:4<1289::aid-cncr2820

    authors: Camus MG,Joshi MG,Mackarem G,Lee AK,Rossi RL,Munson JL,Buyske J,Barbarisi LJ,Sanders LE,Hughes KS

    更新日期:1994-08-15 00:00:00

  • Metastasizing basal cell carcinoma of the skin with myelophthisic anemia.

    abstract::A case report of a metastasizing basal cell carcinoma is presented, primary in the leg with regional inguinal lymph node metastasis, followed by extensive metastasis to skin and bone marrow with myelophthisic anemia and terminal splenohepatic and unilateral adrenal metastasis. ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(196810)22:4<879::aid-cncr2820220

    authors: Coletta DF,Haentze FE,Thomas CC

    更新日期:1968-10-01 00:00:00

  • Efficacy of computed tomography of the thorax and upper abdomen and whole-body gallium scintigraphy for staging of lung cancer.

    abstract::To assess the efficacy of performing both computed tomography (CT) of the thorax and upper abdomen and whole-body gallium scintigraphy for staging lung cancer, the results of each test were compared with those obtained by chest radiography and clinical examination in 100 patients. Clinical efficacy was defined in term...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19891001)64:7<1404::aid-cncr2820

    authors: MacMahon H,Scott W,Ryan JW,Montner SM,Little AG,Hoffman PC,Ferguson MK,Golomb HM

    更新日期:1989-10-01 00:00:00

  • Biodistribution of iodine-125 labeled monoclonal antibody/interleukin-2 immunoconjugate in athymic mice bearing human tumor xenografts.

    abstract:BACKGROUND:Some vasoactive drugs have been studied in the hope of altering the vascular permeability and/or blood of tumors to enhance monoclonal antibody (MoAb) uptake. The pretreatment of interleukin-2 (IL-2), one of the vasoactive reagents, produced a generalized vascular permeability, but its function was not tumor...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19971215)80:12+<2650::aid-

    authors: Nakamura K,Kubo A

    更新日期:1997-12-15 00:00:00

  • Primary care providers' perspectives on discontinuing prostate cancer screening.

    abstract:BACKGROUND:Clinical guidelines recommend against routine prostate-specific antigen (PSA) screening for older men and for those with lower life expectancies. The authors of this report examined providers' decision-making regarding discontinuing PSA screening. METHODS:A survey of primary providers from a large, universi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.27577

    authors: Pollack CE,Platz EA,Bhavsar NA,Noronha G,Green GE,Chen S,Carter HB

    更新日期:2012-11-15 00:00:00

  • Primary intestinal lymphoma with paraproteinemia.

    abstract::Five cases of primary intestinal lymphoma are described. The main clinical features included abdominal pain, diarrhea, and marked weight loss, together with radiologic and some laboratory findings suggestive of malabsorption. Laparatomy perfomed in four cases revealed dilatation of the small intestine, with mesenteric...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197503)35:3<848::aid-cncr2820350

    authors: Shahid MJ,Alami SY,Nassar VH,Balikian JB,Salem AA

    更新日期:1975-03-01 00:00:00

  • The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer.

    abstract:BACKGROUND:Although significant advances have been made in the treatment of some malignancies, the prognosis of patients with metastatic tumors remains poor. Differentiating agents redirect cells toward their normal phenotype and therefore may reverse or suppress evolving malignant lesions or prevent cancer invasion. I...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/(sici)1097-0142(19981015)83:8<1471::aid-cn

    authors: Miller WH Jr

    更新日期:1998-10-15 00:00:00

  • Cytology of myoepithelial carcinoma of the salivary gland.

    abstract:BACKGROUND:Myoepithelial carcinoma, also know as malignant myoepithelioma, is rare in the salivary gland, and its cytologic features have rarely been reported. DESIGN:Four cases of myoepithelial carcinoma with cytology were retrieved from the archives of the Pathology Departments of two academic institutes. In three c...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Chhieng DC,Paulino AF

    更新日期:2002-02-25 00:00:00

  • Immunochemotherapy in human lung cancer using the streptococcal agent OK-432.

    abstract::Streptococcal agent OK-432 was administered at maintenance levels with conventional inductive chemotherapeutic agents to stage III and IV lung cancer patients. Survival rates were longer in patients treated with OK-432 than in patients treated without OK-432. An enhancement of lymphocyte blastogenic activity and a del...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197605)37:5<2201::aid-cncr282037

    authors: Kimura I,Ohnoshi T,Yasuhara S,Sugiyama M,Urabe Y

    更新日期:1976-05-01 00:00:00

  • Prostatic cancer after prostatectomy for benign disease.

    abstract::Twenty of 391 newly diagnosed cases of prostatic cancer (5%) had a prior prostatectomy for benign disease. Digital rectal examination in 16 of 19 patients (84%) revealed a significant prostatic abnormality. Continued serial digital rectal examination should be performed routinely after prostatectomy for benign disease...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19860815)58:4<994::aid-cncr28205

    authors: Schwartz I,Wein AJ,Malloy TR,Glick JH

    更新日期:1986-08-15 00:00:00

  • The epidemiology of renal cell carcinoma. A second look.

    abstract:BACKGROUND:From 1973 to 1991, the incidence of kidney cancer in the United States increased by 35.4%. METHODS:A multicenter, hospital-based case-control study was conducted from 1977 to 1993 through an interview of 788 patients with renal cell carcinoma and 779 control subjects. RESULTS:Compared with those who never ...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/1097-0142(19950515)75:10<2552::aid-cncr282

    authors: Muscat JE,Hoffmann D,Wynder EL

    更新日期:1995-05-15 00:00:00

  • Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology: a decision-curve analysis.

    abstract:BACKGROUND:Several studies have demonstrated that abnormal levels of nuclear matrix protein 22 (NMP22) are associated with bladder cancer and have led to the approval of NMP22 as a urinary biomarker by the US Food and Drug Administration. Nonetheless, the clinical significance of NMP22 remains unclear. The objective of...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.25903

    authors: Shariat SF,Savage C,Chromecki TF,Sun M,Scherr DS,Lee RK,Lughezzani G,Remzi M,Marberger MJ,Karakiewicz PI,Vickers AJ

    更新日期:2011-07-01 00:00:00

  • Trends, patterns, and outcomes in the management of malignant colonic polyps in the general population of the United States.

    abstract:BACKGROUND:Colonoscopic screening has increased detection of malignant colonic polyps (MPs). The goal of this study was to analyze trends and patterns in the surgical treatment of MPs and to assess outcomes as measured by lymph node retrieval and patient survival. METHODS:The Surveillance, Epidemiology, and End Result...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.25657

    authors: Wasif N,Etzioni D,Maggard MA,Tomlinson JS,Ko CY

    更新日期:2011-03-01 00:00:00